Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05020678 |
| Title | NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Nkarta Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Colorado Blood Cancer Institute | Denver | Colorado | 80218 | United States | Details | |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | United States | Details | |
| Institute of Haematology, Royal Prince Alfred Hospital | Camperdown | New South Wales | 2050 | Australia | Details | |
| St. Vincent's Hospital | Sydney | New South Wales | 2010 | Australia | Details | |
| Royal Brisbane and Woman's Hospital | Brisbane | Queensland | 4029 | Australia | Details | |
| Peter MacCallum Cancer Center | Melbourne | Victoria | 3000 | Australia | Details |